Robert Scheinberg, MD
MOHS-Micrographic Surgery · Oceanside, CANPI 1144252388
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $8,938 of the $9,946 with a category attached, or 89.9%. It is spread thinly across 40 manufacturers, the largest accounting for just 16.6% — the pattern of someone who eats at a lot of different presentations.
Across 335 payments — averaging $29.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Stryker$840
- Sanofi$688
- Incyte Corporation$631
- Janssen Scientific Affairs, LLC$617
- Johnson & Johnson$613
- plus $5K from 34 others
Across 34 payments — averaging $3505.03 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Janssen Research & Development, LLC$119K
What the payments were for
- Travel & lodging$8408%
- Food & beverage$8,93890%
- Education$1692%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$9,946 in reported general payments places this provider in the 85th percentile of 144 mohs-micrographic surgery providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ketoconazole | 144 | $2,880 |
| Metronidazole | 41 | $1,642 |
| Triamcinolone Acetonide | 107 | $808 |
| Clobetasol Propionate | 25 | $794 |
| Fluorouracil | 15 | $659 |
| ValacyclovirValacyclovir Hcl | 27 | $561 |
| Clindamycin Phosphate | 18 | $324 |
| SsdSilver Sulfadiazine | 25 | $250 |
| Mupirocin | 30 | $228 |
| Doxycycline Monohydrate | 11 | $174 |
| Mometasone Furoate | 13 | $136 |
| Doxycycline Hyclate | 11 | $96 |
Paid to pharmacies, not to this prescriber.
Other mohs-micrographic surgery in Oceanside
- Susan ShimomayeOceanside$13K
- Alice LiuOceanside$6K
- Sherry RotundaOceanside$6K
- Sarah ArronBurlingame$98K
- Daniel Zelacla Jolla$43K
- Ralph MasseySanta Monica$38K
- Michael MortazieOrange$29K
- Sumaira AasiStanford$27K
- Andrea WilleySacramento$21K
- Benjamin Kelleyla Jolla$20K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.